[1]
MazzantiN.A., ScauriC., DominiB., VassalloC., CusatoS., De FinoC. and de MarinisF. 2019. Advanced-Metastatic Non-Small-Cell Lung Cancer EGFR-mutated in Italy: patient management costs and potential productivity losses. Global & Regional Health Technology Assessment. 6, 1 (Oct. 2019). DOI:https://doi.org/10.33393/grhta.2019.451.